

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular ketone body metabolic process (GO:0046950) | 7.63590904 |
| 2 | flavonoid metabolic process (GO:0009812) | 7.16237303 |
| 3 | viral transcription (GO:0019083) | 6.92564724 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 6.88366211 |
| 5 | translational termination (GO:0006415) | 6.61851812 |
| 6 | ketone body metabolic process (GO:1902224) | 6.59634926 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.48907806 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.90501258 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 5.90501258 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.56100315 |
| 11 | translational elongation (GO:0006414) | 5.54347775 |
| 12 | ribosomal small subunit biogenesis (GO:0042274) | 5.51030974 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 5.46259642 |
| 14 | protein targeting to ER (GO:0045047) | 5.45696301 |
| 15 | * regulation of respiratory burst (GO:0060263) | 5.21248303 |
| 16 | cellular protein complex disassembly (GO:0043624) | 5.19157485 |
| 17 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.19069054 |
| 18 | protein localization to endoplasmic reticulum (GO:0070972) | 5.16851084 |
| 19 | viral life cycle (GO:0019058) | 5.16542720 |
| 20 | negative regulation of epidermal cell differentiation (GO:0045605) | 5.08540175 |
| 21 | ribosomal large subunit biogenesis (GO:0042273) | 5.07290685 |
| 22 | sulfation (GO:0051923) | 4.98693143 |
| 23 | cellular glucuronidation (GO:0052695) | 4.80471097 |
| 24 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.73722593 |
| 25 | mannose metabolic process (GO:0006013) | 4.73559472 |
| 26 | respiratory electron transport chain (GO:0022904) | 4.70001311 |
| 27 | electron transport chain (GO:0022900) | 4.57269105 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.56049250 |
| 29 | keratinocyte development (GO:0003334) | 4.53004175 |
| 30 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.47215693 |
| 31 | protein complex disassembly (GO:0043241) | 4.47012010 |
| 32 | maturation of SSU-rRNA (GO:0030490) | 4.42482997 |
| 33 | uronic acid metabolic process (GO:0006063) | 4.31751698 |
| 34 | glucuronate metabolic process (GO:0019585) | 4.31751698 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.21635473 |
| 36 | positive regulation of chemokine secretion (GO:0090197) | 4.20252130 |
| 37 | regulation of metalloenzyme activity (GO:0048552) | 4.18821385 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 4.17940676 |
| 39 | translational initiation (GO:0006413) | 4.17714158 |
| 40 | regulation of chemokine secretion (GO:0090196) | 4.14280020 |
| 41 | macromolecular complex disassembly (GO:0032984) | 4.12957159 |
| 42 | primary alcohol catabolic process (GO:0034310) | 4.11865673 |
| 43 | antibacterial humoral response (GO:0019731) | 4.11478914 |
| 44 | antimicrobial humoral response (GO:0019730) | 4.10463212 |
| 45 | response to nitrosative stress (GO:0051409) | 4.05886271 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.04391458 |
| 47 | positive regulation of respiratory burst (GO:0060267) | 4.03902034 |
| 48 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.03582232 |
| 49 | intestinal absorption (GO:0050892) | 3.99723205 |
| 50 | bile acid and bile salt transport (GO:0015721) | 3.97729509 |
| 51 | intestinal epithelial cell development (GO:0060576) | 3.97377605 |
| 52 | ethanol metabolic process (GO:0006067) | 3.81680484 |
| 53 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75693343 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74829919 |
| 55 | negative regulation of epidermis development (GO:0045683) | 3.73096469 |
| 56 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.70400042 |
| 57 | phenylpropanoid metabolic process (GO:0009698) | 3.63595795 |
| 58 | ATP biosynthetic process (GO:0006754) | 3.63056967 |
| 59 | proline biosynthetic process (GO:0006561) | 3.62651914 |
| 60 | protein targeting to membrane (GO:0006612) | 3.56797254 |
| 61 | regulation of ARF GTPase activity (GO:0032312) | 3.53666438 |
| 62 | respiratory chain complex IV assembly (GO:0008535) | 3.52543934 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 3.44268432 |
| 64 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.42139870 |
| 65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.41622444 |
| 66 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.41622444 |
| 67 | hepatocyte apoptotic process (GO:0097284) | 3.37998808 |
| 68 | oxidative phosphorylation (GO:0006119) | 3.36286036 |
| 69 | cell-cell junction maintenance (GO:0045217) | 3.35017069 |
| 70 | inner mitochondrial membrane organization (GO:0007007) | 3.34829640 |
| 71 | cytidine deamination (GO:0009972) | 3.26331943 |
| 72 | cytidine metabolic process (GO:0046087) | 3.26331943 |
| 73 | cytidine catabolic process (GO:0006216) | 3.26331943 |
| 74 | glucocorticoid biosynthetic process (GO:0006704) | 3.25496182 |
| 75 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.23762637 |
| 76 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.22729811 |
| 77 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.19408084 |
| 78 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.18172257 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16617843 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16617843 |
| 81 | regulation of vitamin metabolic process (GO:0030656) | 3.13807182 |
| 82 | translation (GO:0006412) | 3.12375173 |
| 83 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.11177933 |
| 84 | galactose catabolic process (GO:0019388) | 3.04400296 |
| 85 | homocysteine metabolic process (GO:0050667) | 3.04300861 |
| 86 | pyrimidine nucleoside salvage (GO:0043097) | 3.01805275 |
| 87 | pyrimidine-containing compound salvage (GO:0008655) | 3.01805275 |
| 88 | negative regulation of cell size (GO:0045792) | 3.01256277 |
| 89 | regulation of cellular extravasation (GO:0002691) | 2.99279348 |
| 90 | semaphorin-plexin signaling pathway (GO:0071526) | 2.98286939 |
| 91 | regulation of viral entry into host cell (GO:0046596) | 2.97979595 |
| 92 | nucleoside salvage (GO:0043174) | 2.96164413 |
| 93 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.95964020 |
| 94 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.93599810 |
| 95 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.91437062 |
| 96 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.90688413 |
| 97 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.90430783 |
| 98 | complement activation, alternative pathway (GO:0006957) | 2.89793753 |
| 99 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.89004118 |
| 100 | negative regulation of viral entry into host cell (GO:0046597) | 2.87145684 |
| 101 | negative regulation of glial cell proliferation (GO:0060253) | 2.87136687 |
| 102 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.87119210 |
| 103 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.86948132 |
| 104 | synaptic vesicle exocytosis (GO:0016079) | 2.84692122 |
| 105 | epithelial structure maintenance (GO:0010669) | 2.84689006 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 2.83683350 |
| 107 | citrulline biosynthetic process (GO:0019240) | 2.82669872 |
| 108 | mRNA catabolic process (GO:0006402) | 2.81852919 |
| 109 | nucleotide-sugar metabolic process (GO:0009225) | 2.81297625 |
| 110 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.80909891 |
| 111 | positive regulation of pseudopodium assembly (GO:0031274) | 2.78460567 |
| 112 | lipopolysaccharide metabolic process (GO:0008653) | 2.77887080 |
| 113 | hydrogen ion transmembrane transport (GO:1902600) | 2.77408331 |
| 114 | positive regulation of protein kinase C signaling (GO:0090037) | 2.73003912 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.68489100 |
| 116 | phospholipid efflux (GO:0033700) | 2.66627973 |
| 117 | activation of Rac GTPase activity (GO:0032863) | 2.65128950 |
| 118 | response to manganese ion (GO:0010042) | 2.60650607 |
| 119 | regulation of ARF protein signal transduction (GO:0032012) | 2.58666275 |
| 120 | positive regulation of histone deacetylation (GO:0031065) | 2.58206599 |
| 121 | cell junction maintenance (GO:0034331) | 2.57738573 |
| 122 | activation of MAPKKK activity (GO:0000185) | 2.57500219 |
| 123 | activation of JUN kinase activity (GO:0007257) | 2.56934196 |
| 124 | regulation of cholesterol esterification (GO:0010872) | 2.55244033 |
| 125 | regulation of cholesterol metabolic process (GO:0090181) | 2.53965519 |
| 126 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.52103349 |
| 127 | regulation of monocyte differentiation (GO:0045655) | 2.52012947 |
| 128 | amyloid precursor protein metabolic process (GO:0042982) | 2.51202213 |
| 129 | protein kinase C signaling (GO:0070528) | 2.50714384 |
| 130 | amyloid precursor protein catabolic process (GO:0042987) | 2.50486959 |
| 131 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50301521 |
| 132 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49178270 |
| 133 | detection of bacterium (GO:0016045) | 2.47303770 |
| 134 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44157214 |
| 135 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44051622 |
| 136 | response to peptidoglycan (GO:0032494) | 2.43905592 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.43184557 |
| 138 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.37950578 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.37357020 |
| 140 | macrophage activation involved in immune response (GO:0002281) | 2.36554791 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.36546215 |
| 142 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.36262922 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35897715 |
| 144 | glycosphingolipid catabolic process (GO:0046479) | 2.33885669 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 2.33820091 |
| 146 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.33051562 |
| 147 | positive regulation of receptor recycling (GO:0001921) | 2.31424742 |
| 148 | glutathione biosynthetic process (GO:0006750) | 2.30617624 |
| 149 | detection of other organism (GO:0098543) | 2.29117706 |
| 150 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28048639 |
| 151 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.27913917 |
| 152 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.27298491 |
| 153 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.27223100 |
| 154 | regulation of ruffle assembly (GO:1900027) | 2.26488715 |
| 155 | apoptotic process involved in morphogenesis (GO:0060561) | 2.25780738 |
| 156 | signal complex assembly (GO:0007172) | 2.25350761 |
| 157 | positive regulation of synapse maturation (GO:0090129) | 2.24844669 |
| 158 | regulation of mast cell degranulation (GO:0043304) | 2.24772340 |
| 159 | positive regulation of lipid catabolic process (GO:0050996) | 2.23953865 |
| 160 | histone H4 deacetylation (GO:0070933) | 2.22098586 |
| 161 | NIK/NF-kappaB signaling (GO:0038061) | 2.22043551 |
| 162 | endothelial cell chemotaxis (GO:0035767) | 2.21661206 |
| 163 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.21572371 |
| 164 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.20159242 |
| 165 | negative regulation of interleukin-2 production (GO:0032703) | 2.18393112 |
| 166 | response to thyroid hormone (GO:0097066) | 2.18267831 |
| 167 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.16308991 |
| 168 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.16123261 |
| 169 | immunoglobulin mediated immune response (GO:0016064) | 2.15528870 |
| 170 | germinal center formation (GO:0002467) | 2.14705423 |
| 171 | thymic T cell selection (GO:0045061) | 2.14615219 |
| 172 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.14323264 |
| 173 | N-acetylneuraminate metabolic process (GO:0006054) | 2.13983805 |
| 174 | protein retention in ER lumen (GO:0006621) | 2.13320644 |
| 175 | cellular response to virus (GO:0098586) | 2.12734587 |
| 176 | histone H3 deacetylation (GO:0070932) | 2.12089117 |
| 177 | regulation of apoptotic cell clearance (GO:2000425) | 2.11659330 |
| 178 | barbed-end actin filament capping (GO:0051016) | 2.11275762 |
| 179 | regulation of regulated secretory pathway (GO:1903305) | 2.10967181 |
| 180 | cell volume homeostasis (GO:0006884) | 2.10896028 |
| 181 | regulation of extracellular matrix disassembly (GO:0010715) | 2.09351099 |
| 182 | urea metabolic process (GO:0019627) | 2.08268843 |
| 183 | glycolipid catabolic process (GO:0019377) | 2.08222876 |
| 184 | positive thymic T cell selection (GO:0045059) | 2.08082351 |
| 185 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.07518213 |
| 186 | UV protection (GO:0009650) | 2.07340241 |
| 187 | positive regulation of Rap GTPase activity (GO:0032854) | 2.06709759 |
| 188 | adenosine receptor signaling pathway (GO:0001973) | 2.05797700 |
| 189 | lytic vacuole organization (GO:0080171) | 2.05543856 |
| 190 | lysosome organization (GO:0007040) | 2.05543856 |
| 191 | Rho protein signal transduction (GO:0007266) | 2.05535460 |
| 192 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.05056036 |
| 193 | urea cycle (GO:0000050) | 2.04610399 |
| 194 | actin filament polymerization (GO:0030041) | 2.04536386 |
| 195 | nitrogen cycle metabolic process (GO:0071941) | 2.03176733 |
| 196 | glutamate secretion (GO:0014047) | 2.02867837 |
| 197 | epithelial cell-cell adhesion (GO:0090136) | 2.02363503 |
| 198 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.01932657 |
| 199 | positive regulation of cholesterol efflux (GO:0010875) | 2.01575283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.60909691 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.61861340 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.47356573 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.35410653 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.85006691 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.70469908 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.47450502 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.40672722 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.39705344 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.39418046 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.20551721 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.96963163 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92524574 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.74984951 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69864989 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.66404384 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64590636 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61010639 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.58339762 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.56350524 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.48036849 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38336806 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.38232724 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.38141789 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.33533178 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31154553 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23796382 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.19666515 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.19611120 |
| 30 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.17845804 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15240489 |
| 32 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.13843854 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12923766 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.11253877 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09675428 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 2.02874422 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01370273 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97117201 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96450278 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.95610357 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94885710 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.90384482 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88872324 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87220687 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85953889 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.77364554 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.76049692 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.75759098 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.75351197 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73070528 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70484743 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.70447271 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.68127102 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66217423 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64957301 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.62486881 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61756597 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.61253625 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60503013 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59871317 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59417020 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.59028895 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58762427 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57770122 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57494208 |
| 66 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57312332 |
| 67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.53938638 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53215696 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51760722 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50826444 |
| 71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.48389202 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48213073 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46612233 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46082231 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45775792 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44163293 |
| 77 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.43077973 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43024988 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42724627 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42321709 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39243587 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38055530 |
| 83 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37682002 |
| 84 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34023064 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33251151 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30772568 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29708875 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28986446 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28632900 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27540983 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27362009 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26904043 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.26113928 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25862482 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25244637 |
| 96 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25030347 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24920224 |
| 98 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24845697 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24182035 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.22952661 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22193415 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.22120704 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20709193 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19821162 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19648108 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19027417 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18960549 |
| 108 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.17359138 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15869031 |
| 110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.15630586 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15197589 |
| 112 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14172740 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11708596 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11536117 |
| 115 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11115180 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11062779 |
| 117 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08144803 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08112699 |
| 119 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07640681 |
| 120 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07514314 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07246946 |
| 122 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06585560 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06296981 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06111775 |
| 125 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05919536 |
| 126 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.03852978 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03562145 |
| 128 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03316185 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03100702 |
| 130 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02986019 |
| 131 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01896461 |
| 132 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01696317 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01571254 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01385644 |
| 135 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01256303 |
| 136 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00967655 |
| 137 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00503574 |
| 138 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00169581 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98314018 |
| 140 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98254798 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98224283 |
| 142 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98144415 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97957990 |
| 144 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97706228 |
| 145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97513719 |
| 146 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97020906 |
| 147 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96190037 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96079888 |
| 149 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96065525 |
| 150 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94958878 |
| 151 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94799605 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94256258 |
| 153 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93184369 |
| 154 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93106667 |
| 155 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91998544 |
| 156 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.91654320 |
| 157 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91179364 |
| 158 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90993147 |
| 159 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89947592 |
| 160 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.89710913 |
| 161 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89236052 |
| 162 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.88393659 |
| 163 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.88351416 |
| 164 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.87542389 |
| 165 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86566494 |
| 166 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85283126 |
| 167 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85059174 |
| 168 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83848659 |
| 169 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83539740 |
| 170 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83539740 |
| 171 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.82499028 |
| 172 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82266570 |
| 173 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.81129560 |
| 174 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79896087 |
| 175 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79158157 |
| 176 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.76852755 |
| 177 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76542041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.35562655 |
| 2 | MP0009379_abnormal_foot_pigmentation | 4.23106260 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.11187669 |
| 4 | MP0000462_abnormal_digestive_system | 3.83770192 |
| 5 | MP0008004_abnormal_stomach_pH | 3.72911017 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.60310257 |
| 7 | MP0005360_urolithiasis | 3.58632562 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.52399035 |
| 9 | MP0001873_stomach_inflammation | 3.30692087 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.30107416 |
| 11 | MP0001666_abnormal_nutrient_absorption | 3.29001702 |
| 12 | MP0003866_abnormal_defecation | 3.20509905 |
| 13 | MP0000490_abnormal_crypts_of | 3.10315335 |
| 14 | MP0010155_abnormal_intestine_physiology | 3.10009756 |
| 15 | MP0001663_abnormal_digestive_system | 2.94665842 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.90980188 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.90196448 |
| 18 | MP0005381_digestive/alimentary_phenotyp | 2.78435143 |
| 19 | MP0003436_decreased_susceptibility_to | 2.73749983 |
| 20 | MP0005365_abnormal_bile_salt | 2.53799499 |
| 21 | MP0003303_peritoneal_inflammation | 2.44862229 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.33022066 |
| 23 | MP0001664_abnormal_digestion | 2.27701466 |
| 24 | MP0009278_abnormal_bone_marrow | 2.26032013 |
| 25 | MP0008260_abnormal_autophagy | 2.25252447 |
| 26 | MP0005409_darkened_coat_color | 2.23266817 |
| 27 | MP0003183_abnormal_peptide_metabolism | 2.22100849 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 2.17299398 |
| 29 | MP0003868_abnormal_feces_composition | 2.16095849 |
| 30 | MP0000477_abnormal_intestine_morphology | 2.15082411 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 2.12868125 |
| 32 | MP0003283_abnormal_digestive_organ | 2.12662339 |
| 33 | MP0003787_abnormal_imprinting | 2.10205362 |
| 34 | MP0005451_abnormal_body_composition | 2.08165041 |
| 35 | MP0003123_paternal_imprinting | 2.03344606 |
| 36 | MP0003300_gastrointestinal_ulcer | 2.02242508 |
| 37 | MP0004510_myositis | 1.93613479 |
| 38 | MP0003075_altered_response_to | 1.85091782 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.80823121 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.80348182 |
| 41 | MP0002132_abnormal_respiratory_system | 1.74617214 |
| 42 | MP0003252_abnormal_bile_duct | 1.72174255 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.71941044 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.71164255 |
| 45 | MP0006054_spinal_hemorrhage | 1.64949159 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.63178489 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.58225708 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.56062003 |
| 49 | MP0000470_abnormal_stomach_morphology | 1.51019938 |
| 50 | MP0003690_abnormal_glial_cell | 1.47391215 |
| 51 | MP0004858_abnormal_nervous_system | 1.47131508 |
| 52 | MP0003329_amyloid_beta_deposits | 1.43229172 |
| 53 | MP0005670_abnormal_white_adipose | 1.42341547 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.41897718 |
| 55 | MP0002419_abnormal_innate_immunity | 1.41748068 |
| 56 | MP0002796_impaired_skin_barrier | 1.39558561 |
| 57 | MP0003567_abnormal_fetal_cardiomyocyte | 1.39162224 |
| 58 | MP0005083_abnormal_biliary_tract | 1.35537960 |
| 59 | MP0000604_amyloidosis | 1.35122750 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.35063363 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.34331253 |
| 62 | MP0003011_delayed_dark_adaptation | 1.34104945 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.31339710 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.31162840 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.30565218 |
| 66 | MP0009840_abnormal_foam_cell | 1.30497416 |
| 67 | MP0004019_abnormal_vitamin_homeostasis | 1.29864303 |
| 68 | MP0009785_altered_susceptibility_to | 1.29394594 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.27783993 |
| 70 | MP0004947_skin_inflammation | 1.27580252 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.27183547 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.26042002 |
| 73 | MP0005387_immune_system_phenotype | 1.25360499 |
| 74 | MP0001790_abnormal_immune_system | 1.25360499 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.25159820 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.24921721 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.22513650 |
| 78 | MP0008874_decreased_physiological_sensi | 1.21972320 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.19229380 |
| 80 | MP0006082_CNS_inflammation | 1.18557949 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.18395397 |
| 82 | MP0002060_abnormal_skin_morphology | 1.18180569 |
| 83 | MP0001765_abnormal_ion_homeostasis | 1.16502359 |
| 84 | MP0001849_ear_inflammation | 1.15253261 |
| 85 | MP0000537_abnormal_urethra_morphology | 1.14577218 |
| 86 | MP0002933_joint_inflammation | 1.13938127 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.13396461 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 1.11679692 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.08924302 |
| 90 | MP0008872_abnormal_physiological_respon | 1.08814974 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.08420408 |
| 92 | MP0004381_abnormal_hair_follicle | 1.08062083 |
| 93 | MP0002998_abnormal_bone_remodeling | 1.05684656 |
| 94 | MP0003315_abnormal_perineum_morphology | 1.05535634 |
| 95 | MP0003941_abnormal_skin_development | 1.04496433 |
| 96 | MP0001835_abnormal_antigen_presentation | 1.04281849 |
| 97 | MP0003724_increased_susceptibility_to | 1.03884518 |
| 98 | MP0002006_tumorigenesis | 1.02334184 |
| 99 | MP0000751_myopathy | 1.01920719 |
| 100 | MP0005535_abnormal_body_temperature | 1.01610118 |
| 101 | MP0002723_abnormal_immune_serum | 1.00306237 |
| 102 | MP0000681_abnormal_thyroid_gland | 0.99757186 |
| 103 | MP0002118_abnormal_lipid_homeostasis | 0.96435550 |
| 104 | MP0010678_abnormal_skin_adnexa | 0.96366573 |
| 105 | MP0000858_altered_metastatic_potential | 0.96186351 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.95523495 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.95057665 |
| 108 | MP0001800_abnormal_humoral_immune | 0.93039603 |
| 109 | MP0000685_abnormal_immune_system | 0.92366399 |
| 110 | MP0005332_abnormal_amino_acid | 0.91247421 |
| 111 | MP0001764_abnormal_homeostasis | 0.91037946 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.88258903 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.88211401 |
| 114 | MP0001502_abnormal_circadian_rhythm | 0.87897831 |
| 115 | MP0001819_abnormal_immune_cell | 0.87840069 |
| 116 | MP0005501_abnormal_skin_physiology | 0.87229761 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.85668953 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.85400446 |
| 119 | MP0003191_abnormal_cellular_cholesterol | 0.85206353 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.83811987 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.83605608 |
| 122 | MP0005310_abnormal_salivary_gland | 0.83307662 |
| 123 | MP0000920_abnormal_myelination | 0.83218941 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.82823339 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.82608183 |
| 126 | MP0003879_abnormal_hair_cell | 0.80684796 |
| 127 | MP0002822_catalepsy | 0.79657347 |
| 128 | MP0005671_abnormal_response_to | 0.78134004 |
| 129 | MP0003634_abnormal_glial_cell | 0.78113040 |
| 130 | MP0003186_abnormal_redox_activity | 0.77390239 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.77069796 |
| 132 | MP0003279_aneurysm | 0.77002295 |
| 133 | MP0005025_abnormal_response_to | 0.74360916 |
| 134 | MP0002064_seizures | 0.73617710 |
| 135 | MP0000613_abnormal_salivary_gland | 0.73150888 |
| 136 | MP0000747_muscle_weakness | 0.73038280 |
| 137 | MP0000249_abnormal_blood_vessel | 0.72798149 |
| 138 | MP0001756_abnormal_urination | 0.71434566 |
| 139 | MP0005166_decreased_susceptibility_to | 0.71030663 |
| 140 | MP0005220_abnormal_exocrine_pancreas | 0.70975719 |
| 141 | MP0010771_integument_phenotype | 0.70584884 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.68669738 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.67555929 |
| 144 | MP0001545_abnormal_hematopoietic_system | 0.67555929 |
| 145 | MP0009697_abnormal_copulation | 0.66728674 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.66445833 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.65748344 |
| 148 | MP0002009_preneoplasia | 0.65673832 |
| 149 | MP0000467_abnormal_esophagus_morphology | 0.65404270 |
| 150 | MP0003878_abnormal_ear_physiology | 0.64477840 |
| 151 | MP0005377_hearing/vestibular/ear_phenot | 0.64477840 |
| 152 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62982294 |
| 153 | MP0000609_abnormal_liver_physiology | 0.60893747 |
| 154 | MP0003119_abnormal_digestive_system | 0.59469183 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.57795124 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.56933500 |
| 157 | MP0002148_abnormal_hypersensitivity_rea | 0.56416493 |
| 158 | MP0008469_abnormal_protein_level | 0.55930255 |
| 159 | MP0002254_reproductive_system_inflammat | 0.55904567 |
| 160 | MP0000383_abnormal_hair_follicle | 0.55659773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 5.70897280 |
| 2 | Ventricular fibrillation (HP:0001663) | 5.49944489 |
| 3 | Increased intramyocellular lipid droplets (HP:0012240) | 5.42113000 |
| 4 | Abnormal hemoglobin (HP:0011902) | 5.15379676 |
| 5 | Increased muscle lipid content (HP:0009058) | 5.07653975 |
| 6 | Macrocytic anemia (HP:0001972) | 4.40824723 |
| 7 | J-shaped sella turcica (HP:0002680) | 4.40075359 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.38253599 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 4.32565350 |
| 10 | Reticulocytopenia (HP:0001896) | 4.19540240 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.12534380 |
| 12 | Metabolic alkalosis (HP:0200114) | 4.03451294 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.99733715 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.95852065 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.95124647 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.91624286 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.82377922 |
| 18 | Hepatic necrosis (HP:0002605) | 3.81380080 |
| 19 | Congenital sensorineural hearing impairment (HP:0008527) | 3.77301647 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.75292908 |
| 21 | Hepatocellular necrosis (HP:0001404) | 3.73588879 |
| 22 | Decreased circulating renin level (HP:0003351) | 3.70823713 |
| 23 | Pustule (HP:0200039) | 3.65005455 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.60881111 |
| 25 | Pallor (HP:0000980) | 3.56447134 |
| 26 | Exertional dyspnea (HP:0002875) | 3.52598388 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.49717238 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.42894102 |
| 29 | Mucopolysacchariduria (HP:0008155) | 3.42894102 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.41881132 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.41881132 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.41881132 |
| 33 | Abnormality of urine glucose concentration (HP:0011016) | 3.34030296 |
| 34 | Glycosuria (HP:0003076) | 3.34030296 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.25987827 |
| 36 | Loss of speech (HP:0002371) | 3.22764793 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.19742471 |
| 38 | Axonal loss (HP:0003447) | 3.13408206 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10893984 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10893984 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10893984 |
| 42 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.10799134 |
| 43 | Pili torti (HP:0003777) | 3.06308692 |
| 44 | Neurofibrillary tangles (HP:0002185) | 3.05917820 |
| 45 | Stridor (HP:0010307) | 3.05693014 |
| 46 | Nuclear cataract (HP:0100018) | 3.05363971 |
| 47 | Glomerulonephritis (HP:0000099) | 3.01376518 |
| 48 | Increased CSF lactate (HP:0002490) | 2.99206770 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 2.95536121 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.92050799 |
| 51 | Myokymia (HP:0002411) | 2.90322791 |
| 52 | Colitis (HP:0002583) | 2.89017451 |
| 53 | Increased serum lactate (HP:0002151) | 2.88712659 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.87951616 |
| 55 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.83526855 |
| 56 | Sensory axonal neuropathy (HP:0003390) | 2.76649863 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.75806402 |
| 58 | Abnormality of renal resorption (HP:0011038) | 2.74325161 |
| 59 | Abnormal hair laboratory examination (HP:0003328) | 2.72318371 |
| 60 | Complement deficiency (HP:0004431) | 2.71113310 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.70465811 |
| 62 | Deep venous thrombosis (HP:0002625) | 2.68927916 |
| 63 | Cervical subluxation (HP:0003308) | 2.66154802 |
| 64 | Broad face (HP:0000283) | 2.65458034 |
| 65 | Rectal prolapse (HP:0002035) | 2.59632837 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58569760 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58569760 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55638897 |
| 69 | Hyperammonemia (HP:0001987) | 2.54264228 |
| 70 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.54228204 |
| 71 | Villous atrophy (HP:0011473) | 2.54228204 |
| 72 | Thrombocytosis (HP:0001894) | 2.50561474 |
| 73 | Thin bony cortex (HP:0002753) | 2.50461643 |
| 74 | Distal lower limb muscle weakness (HP:0009053) | 2.49861905 |
| 75 | Malnutrition (HP:0004395) | 2.49057149 |
| 76 | Abnormality of complement system (HP:0005339) | 2.48634887 |
| 77 | Acute encephalopathy (HP:0006846) | 2.47908527 |
| 78 | Joint stiffness (HP:0001387) | 2.47250470 |
| 79 | Woolly hair (HP:0002224) | 2.46160734 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45144768 |
| 81 | Cheilitis (HP:0100825) | 2.44866676 |
| 82 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.44444340 |
| 83 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44117913 |
| 84 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.43506756 |
| 85 | 3-Methylglutaconic aciduria (HP:0003535) | 2.43016792 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.42703272 |
| 87 | Ankle clonus (HP:0011448) | 2.42621141 |
| 88 | Abdominal distention (HP:0003270) | 2.42207979 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.42166774 |
| 90 | Distal upper limb amyotrophy (HP:0007149) | 2.41553516 |
| 91 | Upper limb amyotrophy (HP:0009129) | 2.41553516 |
| 92 | Micronodular cirrhosis (HP:0001413) | 2.39356817 |
| 93 | Respiratory difficulties (HP:0002880) | 2.38830124 |
| 94 | Alkalosis (HP:0001948) | 2.38506132 |
| 95 | Ridged nail (HP:0001807) | 2.35989664 |
| 96 | Deformed sella turcica (HP:0002681) | 2.35196919 |
| 97 | Abnormality of renin-angiotensin system (HP:0000847) | 2.34019771 |
| 98 | Flat acetabular roof (HP:0003180) | 2.33090967 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 2.32364709 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.30755974 |
| 101 | Abnormality of vitamin B metabolism (HP:0004340) | 2.30424812 |
| 102 | Lymphangioma (HP:0100764) | 2.30424764 |
| 103 | Biliary tract neoplasm (HP:0100574) | 2.27930003 |
| 104 | Visual hallucinations (HP:0002367) | 2.27842567 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 2.27156984 |
| 106 | Amyloidosis (HP:0011034) | 2.27019731 |
| 107 | Myositis (HP:0100614) | 2.26602123 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 2.24418221 |
| 109 | Gastrointestinal dysmotility (HP:0002579) | 2.24291213 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 2.23250919 |
| 111 | Purpura (HP:0000979) | 2.22985765 |
| 112 | Gingivitis (HP:0000230) | 2.19271069 |
| 113 | Bulbar palsy (HP:0001283) | 2.19069460 |
| 114 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18906138 |
| 115 | Male infertility (HP:0003251) | 2.17788246 |
| 116 | Generalized aminoaciduria (HP:0002909) | 2.17287676 |
| 117 | Hypoglycemic coma (HP:0001325) | 2.16800070 |
| 118 | Recurrent abscess formation (HP:0002722) | 2.16722023 |
| 119 | Easy fatigability (HP:0003388) | 2.15534994 |
| 120 | Thoracic kyphosis (HP:0002942) | 2.15513213 |
| 121 | Abnormality of chloride homeostasis (HP:0011422) | 2.14597973 |
| 122 | Lactic acidosis (HP:0003128) | 2.13697644 |
| 123 | Colon cancer (HP:0003003) | 2.13499082 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 2.11975059 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 2.11846881 |
| 126 | Posterior subcapsular cataract (HP:0007787) | 2.09543568 |
| 127 | Dicarboxylic aciduria (HP:0003215) | 2.09105208 |
| 128 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09105208 |
| 129 | 11 pairs of ribs (HP:0000878) | 2.07447197 |
| 130 | Inflammation of the large intestine (HP:0002037) | 2.07426507 |
| 131 | Fat malabsorption (HP:0002630) | 2.05314999 |
| 132 | Growth hormone excess (HP:0000845) | 2.04843692 |
| 133 | Trismus (HP:0000211) | 2.04520725 |
| 134 | Abnormality of the thoracic spine (HP:0100711) | 2.03814696 |
| 135 | Syncope (HP:0001279) | 2.03213451 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 2.03119577 |
| 137 | Hypophosphatemia (HP:0002148) | 2.03078287 |
| 138 | Abnormality of macrophages (HP:0004311) | 2.02812189 |
| 139 | Nephritis (HP:0000123) | 2.02621794 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 2.02029931 |
| 141 | Muscle stiffness (HP:0003552) | 2.01394226 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 2.01020748 |
| 143 | Myopathic facies (HP:0002058) | 2.00572527 |
| 144 | Lethargy (HP:0001254) | 2.00226030 |
| 145 | Onycholysis (HP:0001806) | 2.00107823 |
| 146 | Abnormality of the costochondral junction (HP:0000919) | 1.99918287 |
| 147 | Microvesicular hepatic steatosis (HP:0001414) | 1.99163165 |
| 148 | Obstructive lung disease (HP:0006536) | 1.99128447 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99128447 |
| 150 | Abnormal biliary tract morphology (HP:0012440) | 1.98224963 |
| 151 | Polygenic inheritance (HP:0010982) | 1.97976817 |
| 152 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95762515 |
| 153 | Dementia (HP:0000726) | 1.95099497 |
| 154 | Increased IgE level (HP:0003212) | 1.95046106 |
| 155 | Hyperacusis (HP:0010780) | 1.94356891 |
| 156 | Milia (HP:0001056) | 1.93971170 |
| 157 | Cellulitis (HP:0100658) | 1.93924463 |
| 158 | Abnormal EKG (HP:0003115) | 1.93677255 |
| 159 | Abnormal urine phosphate concentration (HP:0012599) | 1.93020343 |
| 160 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92937026 |
| 161 | Progressive macrocephaly (HP:0004481) | 1.92195557 |
| 162 | Cerebral edema (HP:0002181) | 1.92186140 |
| 163 | Dehydration (HP:0001944) | 1.91482641 |
| 164 | Increased serum ferritin (HP:0003281) | 1.90874252 |
| 165 | Seborrheic dermatitis (HP:0001051) | 1.90769697 |
| 166 | Atelectasis (HP:0100750) | 1.90213256 |
| 167 | Hypertriglyceridemia (HP:0002155) | 1.89691891 |
| 168 | Spinal canal stenosis (HP:0003416) | 1.89605382 |
| 169 | Exercise intolerance (HP:0003546) | 1.89330548 |
| 170 | Abnormality of the periventricular white matter (HP:0002518) | 1.89242892 |
| 171 | Abnormality of lateral ventricle (HP:0030047) | 1.88888556 |
| 172 | Exercise-induced myalgia (HP:0003738) | 1.88262782 |
| 173 | Vacuolated lymphocytes (HP:0001922) | 1.88130603 |
| 174 | Fragile skin (HP:0001030) | 1.88065353 |
| 175 | Xanthomatosis (HP:0000991) | 1.87145672 |
| 176 | Interstitial pulmonary disease (HP:0006530) | 1.86931868 |
| 177 | Palpitations (HP:0001962) | 1.86811942 |
| 178 | Hypobetalipoproteinemia (HP:0003563) | 1.86193424 |
| 179 | Aplastic anemia (HP:0001915) | 1.84942045 |
| 180 | Emphysema (HP:0002097) | 1.83016793 |
| 181 | Diaphragmatic weakness (HP:0009113) | 1.82047199 |
| 182 | Abnormality of the Achilles tendon (HP:0005109) | 1.81822196 |
| 183 | Nasal polyposis (HP:0100582) | 1.81457375 |
| 184 | Prolonged QT interval (HP:0001657) | 1.80742126 |
| 185 | Visceral angiomatosis (HP:0100761) | 1.79607127 |
| 186 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78334386 |
| 187 | Achilles tendon contracture (HP:0001771) | 1.77891000 |
| 188 | Neurodegeneration (HP:0002180) | 1.75346263 |
| 189 | Flattened epiphyses (HP:0003071) | 1.73414471 |
| 190 | Protuberant abdomen (HP:0001538) | 1.72705330 |
| 191 | Cerebral palsy (HP:0100021) | 1.70450214 |
| 192 | Orchitis (HP:0100796) | 1.69574438 |
| 193 | Mutism (HP:0002300) | 1.68580944 |
| 194 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.68448257 |
| 195 | Annular pancreas (HP:0001734) | 1.68042342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.48400858 |
| 2 | FRK | 4.89175914 |
| 3 | EIF2AK1 | 4.27045728 |
| 4 | TRIB3 | 4.06171976 |
| 5 | MAP2K6 | 3.71012660 |
| 6 | SIK1 | 3.26756124 |
| 7 | PRKG2 | 2.72668981 |
| 8 | MST1R | 2.70142114 |
| 9 | MAP2K2 | 2.69659235 |
| 10 | TLK1 | 2.69165534 |
| 11 | PBK | 2.54493560 |
| 12 | BUB1 | 2.41342604 |
| 13 | STK16 | 2.25787476 |
| 14 | TNK2 | 2.23721808 |
| 15 | NME1 | 2.22440428 |
| 16 | MST4 | 2.06559676 |
| 17 | PRPF4B | 1.97315372 |
| 18 | STK39 | 1.88692626 |
| 19 | NME2 | 1.88082213 |
| 20 | RIPK4 | 1.88041837 |
| 21 | NUAK1 | 1.85437168 |
| 22 | TAOK3 | 1.83229660 |
| 23 | ERN1 | 1.82600870 |
| 24 | TESK2 | 1.76385893 |
| 25 | BCKDK | 1.70231414 |
| 26 | MARK2 | 1.69662992 |
| 27 | MAP3K11 | 1.68865356 |
| 28 | PIK3CA | 1.68100615 |
| 29 | ABL2 | 1.64192111 |
| 30 | PRKD2 | 1.57605662 |
| 31 | MAP3K2 | 1.55045167 |
| 32 | RPS6KB2 | 1.50663782 |
| 33 | SMG1 | 1.48202757 |
| 34 | MAP3K13 | 1.43203952 |
| 35 | SIK2 | 1.39800660 |
| 36 | MAP3K6 | 1.35618481 |
| 37 | FGFR4 | 1.34557618 |
| 38 | TTK | 1.31372964 |
| 39 | ICK | 1.27919423 |
| 40 | NTRK3 | 1.26213430 |
| 41 | MYLK | 1.24512893 |
| 42 | DAPK2 | 1.21832922 |
| 43 | PKN2 | 1.15458145 |
| 44 | MAPK12 | 1.15191758 |
| 45 | MAP3K8 | 1.13882319 |
| 46 | MAP3K12 | 1.11601938 |
| 47 | PRKD3 | 1.10476785 |
| 48 | CDC42BPA | 1.07157420 |
| 49 | AURKB | 1.06525523 |
| 50 | ERBB2 | 1.06054739 |
| 51 | RPS6KA2 | 1.03467546 |
| 52 | BMX | 1.01794385 |
| 53 | PDPK1 | 1.01109398 |
| 54 | TAOK2 | 1.00080889 |
| 55 | TEC | 0.97540372 |
| 56 | KSR2 | 0.97262473 |
| 57 | EPHB2 | 0.95729004 |
| 58 | MAP4K1 | 0.91779012 |
| 59 | TYK2 | 0.90673187 |
| 60 | IRAK2 | 0.90635420 |
| 61 | EPHA2 | 0.89839849 |
| 62 | SIK3 | 0.89316873 |
| 63 | MAP3K1 | 0.88285943 |
| 64 | WEE1 | 0.87798574 |
| 65 | BLK | 0.87697674 |
| 66 | GRK6 | 0.83976165 |
| 67 | DDR2 | 0.83588381 |
| 68 | ZAP70 | 0.83279667 |
| 69 | PTK6 | 0.83174434 |
| 70 | RPS6KC1 | 0.82527006 |
| 71 | RPS6KL1 | 0.82527006 |
| 72 | CCNB1 | 0.80480909 |
| 73 | MAPK15 | 0.80284318 |
| 74 | HIPK2 | 0.78882669 |
| 75 | ARAF | 0.78347566 |
| 76 | IKBKE | 0.76960254 |
| 77 | TBK1 | 0.76844756 |
| 78 | LRRK2 | 0.74461898 |
| 79 | DYRK1B | 0.74393645 |
| 80 | EPHA4 | 0.73980943 |
| 81 | TESK1 | 0.73925927 |
| 82 | FES | 0.73420283 |
| 83 | CSK | 0.73001831 |
| 84 | EPHB1 | 0.71207144 |
| 85 | MAPKAPK3 | 0.70824669 |
| 86 | PAK4 | 0.70217663 |
| 87 | PDK1 | 0.70172486 |
| 88 | STK38 | 0.69870284 |
| 89 | MAPK7 | 0.68726792 |
| 90 | BRSK1 | 0.68258903 |
| 91 | RPS6KA6 | 0.65928148 |
| 92 | RIPK1 | 0.65715753 |
| 93 | GRK1 | 0.65476302 |
| 94 | MAP3K14 | 0.63912424 |
| 95 | OXSR1 | 0.63487901 |
| 96 | IRAK4 | 0.63484735 |
| 97 | EEF2K | 0.63072654 |
| 98 | EIF2AK2 | 0.62628109 |
| 99 | CDK19 | 0.62348464 |
| 100 | DAPK1 | 0.61982646 |
| 101 | MAP2K4 | 0.61061974 |
| 102 | MAP3K3 | 0.60762465 |
| 103 | LATS1 | 0.59736726 |
| 104 | PAK6 | 0.59706720 |
| 105 | WNK4 | 0.59631815 |
| 106 | MATK | 0.58835128 |
| 107 | BTK | 0.57899686 |
| 108 | IRAK3 | 0.57211016 |
| 109 | KDR | 0.56257686 |
| 110 | PIK3CG | 0.55321974 |
| 111 | MTOR | 0.54569904 |
| 112 | PIM2 | 0.52809319 |
| 113 | CDK6 | 0.48813360 |
| 114 | MAPK4 | 0.47384254 |
| 115 | MUSK | 0.47261942 |
| 116 | MAP2K1 | 0.46914436 |
| 117 | IKBKB | 0.46478935 |
| 118 | PRKD1 | 0.46316262 |
| 119 | TTN | 0.45524140 |
| 120 | PRKCH | 0.44780683 |
| 121 | TYRO3 | 0.44351564 |
| 122 | FGR | 0.43803256 |
| 123 | CHUK | 0.43509877 |
| 124 | CAMK1 | 0.42000558 |
| 125 | MAPK11 | 0.41992803 |
| 126 | PLK1 | 0.41564460 |
| 127 | CSNK2A2 | 0.40752427 |
| 128 | SYK | 0.39303884 |
| 129 | BRSK2 | 0.38667800 |
| 130 | MAPK8 | 0.38518856 |
| 131 | PRKCI | 0.37047919 |
| 132 | RPS6KA1 | 0.36667823 |
| 133 | PLK4 | 0.35779188 |
| 134 | PASK | 0.34644100 |
| 135 | CAMK2D | 0.32679896 |
| 136 | MAP2K3 | 0.32545590 |
| 137 | CDK4 | 0.31546841 |
| 138 | * PRKCA | 0.30490018 |
| 139 | TIE1 | 0.30431763 |
| 140 | LCK | 0.29750158 |
| 141 | CAMK2G | 0.28913435 |
| 142 | CSF1R | 0.28200989 |
| 143 | PTK2 | 0.27404787 |
| 144 | CSNK2A1 | 0.27259209 |
| 145 | MAP3K7 | 0.25904504 |
| 146 | CAMKK1 | 0.25846439 |
| 147 | CSNK1A1 | 0.24976447 |
| 148 | JAK2 | 0.24575379 |
| 149 | TGFBR2 | 0.23869962 |
| 150 | CAMK2B | 0.23028436 |
| 151 | TAOK1 | 0.22550543 |
| 152 | JAK3 | 0.21964438 |
| 153 | FLT3 | 0.21797356 |
| 154 | MAP3K10 | 0.20792719 |
| 155 | MET | 0.19526992 |
| 156 | AURKA | 0.18873251 |
| 157 | LYN | 0.18682092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.45756785 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.18504797 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.16686834 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.67515562 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83283964 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79414327 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52660896 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.50919627 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.47023203 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16778030 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07238239 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05264684 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.02232683 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.00805817 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00196383 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93551055 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89705386 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87612997 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.82155176 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.79924816 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.79416664 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78878540 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.73460061 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71602418 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.70969240 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67937970 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64683423 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62549888 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52267605 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49503053 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48331309 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39742097 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36527519 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.35825409 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35636167 |
| 36 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.35556158 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29595709 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28739728 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.26423545 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.21165996 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20690194 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.20167319 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19606248 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18600183 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18566173 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16851925 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16790011 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16654020 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.14365476 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14297430 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11791369 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11270445 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08042560 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07695907 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07673825 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06241873 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05165529 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.04427599 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01462030 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00466944 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00074325 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.99372077 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99325450 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98474523 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97647267 |
| 66 | Mismatch repair_Homo sapiens_hsa03430 | 0.96744397 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.93545788 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93091512 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92814136 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92317501 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.91578143 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91344889 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90846424 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89565396 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.88768748 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88554457 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87671500 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87598103 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87077960 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87061411 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86289636 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.85508223 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84851307 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84315678 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83521916 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83079729 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82559578 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81353859 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81207931 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80516399 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77798564 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77668319 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77059192 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76040490 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75929118 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75796193 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74433867 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72363082 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70867452 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70561567 |
| 101 | Homologous recombination_Homo sapiens_hsa03440 | 0.70418750 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69722668 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.69635779 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69570137 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69118826 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68458052 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67471025 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67358004 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.66812788 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64642116 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64440370 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64215934 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63962187 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63255943 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63018246 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62932636 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.62462327 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62216441 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61587339 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61396146 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61129860 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60478209 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60417174 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60392229 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.60021479 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59898830 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.59076440 |
| 128 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58295440 |
| 129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57715775 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57536549 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57292300 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57043498 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56687600 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56038523 |
| 135 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55561833 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54962261 |
| 137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54738921 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.54018513 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.53777070 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.52932356 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50461356 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.47735780 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47684980 |
| 144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47287730 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46127843 |
| 146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45781818 |
| 147 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45781608 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.45468548 |
| 149 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45035676 |
| 150 | Renin secretion_Homo sapiens_hsa04924 | 0.44427121 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44274991 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44273038 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43150634 |
| 154 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42415839 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42020516 |
| 156 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40816785 |
| 157 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40658707 |
| 158 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39507657 |
| 159 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38994466 |
| 160 | ABC transporters_Homo sapiens_hsa02010 | 0.38021065 |
| 161 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37752426 |
| 162 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31790897 |
| 163 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29635523 |
| 164 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28642828 |
| 165 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27480500 |
| 166 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27277676 |
| 167 | Protein export_Homo sapiens_hsa03060 | 0.24895331 |
| 168 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24001957 |
| 169 | Purine metabolism_Homo sapiens_hsa00230 | 0.23651366 |
| 170 | Influenza A_Homo sapiens_hsa05164 | 0.21108125 |
| 171 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18943522 |
| 172 | Pertussis_Homo sapiens_hsa05133 | 0.18315964 |
| 173 | Base excision repair_Homo sapiens_hsa03410 | 0.18246388 |
| 174 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17016096 |
| 175 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16655892 |
| 176 | Legionellosis_Homo sapiens_hsa05134 | 0.16313042 |
| 177 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.15129119 |

